A Hamilton patient is the first trial participant to receive a novel experimental immunotherapy treatment for lung cancer.
McMaster, along with The Ottawa Hospital, the Children’s Hospital of Eastern Ontario and the University of Ottawa have congratulated Turnstone Biologics Inc.3 on securing $41.4 million U.S. in new private investments.
McMaster logo
McMaster logo
